116 related articles for article (PubMed ID: 156427)
21. Correlation of visual 51Cr release and flow cytometry crossmatch results and graft survival.
Kerman R; Van Buren CT; Flechner S; Kahan BD
Transplant Proc; 1984 Dec; 16(6):1430-3. PubMed ID: 6390843
[No Abstract] [Full Text] [Related]
22. [Mixed lymphocyte culture (MLC) as a histocompatibility test for allogen grafts. Part II. technique, significance and applications (author's transl)].
Vogel I; Moser C
Wien Klin Wochenschr; 1977 Oct; 89(19):640-3. PubMed ID: 143799
[TBL] [Abstract][Full Text] [Related]
23. MLC, PHA, HLA, and DRw studies in renal allografting.
Braun WE; Jayavant M; Dejelo C; Zachary A; Novick A; Santos N; Williams T
Transplant Proc; 1979 Dec; 11(4):1911-3. PubMed ID: 161103
[No Abstract] [Full Text] [Related]
24. The correlation of MLC with graft survival.
Cochrum KC; Perkins HA; Payne RO; Kountz SL; Belzer FO
Transplant Proc; 1973 Mar; 5(1):391-6. PubMed ID: 4266666
[No Abstract] [Full Text] [Related]
25. The mixed lymphocyte culture test.
Med J Aust; 1979 Nov; 2(10):526-7. PubMed ID: 160980
[No Abstract] [Full Text] [Related]
26. MLC and HLA-DR typing: their relationship and relevance for transplantation.
Cullen PR; Ting A; Morris PJ
Transplant Proc; 1979 Mar; 11(1):756-9. PubMed ID: 156433
[No Abstract] [Full Text] [Related]
27. The influence of HLA-D matching on the outcome of intrafamilial kidney transplantation with special emphasis on the predictive value of the relative response in MLC.
Berg B; Groth CG; Lundgren G; Magnusson G; Möller E; Ringdén O
Scand J Urol Nephrol Suppl; 1981; 64():46-51. PubMed ID: 6216584
[TBL] [Abstract][Full Text] [Related]
28. Regulation of T-cell-mediated cytotoxic allograft response in human transplant recipients.
Thomas J; Thomas F; Edwards E; Hoffman S; Lee HM
Transplant Proc; 1981 Sep; 13(3):1594-8. PubMed ID: 6458130
[No Abstract] [Full Text] [Related]
29. Immunologic preparation for cadaver renal transplant by thoracic duct drainage.
Johnson HK; Niblack GD; Tallent MB; Richie RE
Transplant Proc; 1977 Sep; 9(3):1499-1503. PubMed ID: 143094
[No Abstract] [Full Text] [Related]
30. Graft survival in unrelated donor--recipient pairs matched for MLC and HL-A.
van Rood JJ; Koch CT; van Hooff JP; van Leeuwen A; van den Tweel JG; Frederiks E; Schippers HM; Hendriks G; van der Steen GJ
Transplant Proc; 1973 Mar; 5(1):409-14. PubMed ID: 4266668
[No Abstract] [Full Text] [Related]
31. Donor-specific transfusion (DST) with intermittent administration of azathioprine induces suppressor T cells and MLR-inhibiting factors without sensitization.
Haisa M; Sakagami K; Matsumoto T; Kawamura T; Uchida S; Fujiwara T; Shiozaki S; Inagaki M; Orita K
Transplant Proc; 1989 Feb; 21(1 Pt 2):1814-7. PubMed ID: 2523594
[No Abstract] [Full Text] [Related]
32. Cross-reactive antibodies and decreased renal graft survival.
Garovoy MR; Cho S; Carpenter CB
Transplant Proc; 1979 Mar; 11(1):370-3. PubMed ID: 377658
[No Abstract] [Full Text] [Related]
33. A 14-year experience with kidney transplantation.
Weil R; Schröter GP; West JC; Starzl TE
World J Surg; 1977 Mar; 2(1):145-56. PubMed ID: 141173
[TBL] [Abstract][Full Text] [Related]
34. Related donor kidney transplantation is the best form of treatment for uremia.
Groth CG; Fehrman I; Ringdén O; Lundgren G
Transplant Proc; 1987 Feb; 19(1 Pt 3):2278-9. PubMed ID: 2978893
[No Abstract] [Full Text] [Related]
35. Donor-specific blood transfusions in HLA-D-disparate one-haplotype-related allografts.
Cochrum KC; Hanes D; Potter D; Vincenti F; Amend W; Feduska N; Perkins H; Salvatierra O
Transplant Proc; 1979 Dec; 11(4):1903-7. PubMed ID: 161102
[No Abstract] [Full Text] [Related]
36. [Significance of histocompatibility tests].
Nishigaki F; Nozaki M; Nakamura A; Taniguchi M; Kobayashi K; Hirano T
Rinsho Byori; 1990 Feb; 38(2):151-6. PubMed ID: 2139476
[TBL] [Abstract][Full Text] [Related]
37. Improving graft and patient survival rates in renal transplantation.
Corry RJ; West JC; Goeken N; Oei LS
Proc Clin Dial Transplant Forum; 1979; 9():214-8. PubMed ID: 399510
[TBL] [Abstract][Full Text] [Related]
38. Effects of histocompatibility testing versus immunoreactive predisposition on kidney transplant survival.
Kyriakides GK; Severyn W; Fuller L; Esquenazi V; Flaa C; Olson L; Miller J
Surgery; 1982 Aug; 92(2):354-61. PubMed ID: 6213054
[TBL] [Abstract][Full Text] [Related]
39. Lymphocytapheresis as pretransplant immunosuppression.
Tajima A; Aso Y; Suzuki K; Ohtawara Y; Ohta N; Hata M; Ushiyama T; Nakano M; Yaguchi Y
Transplant Proc; 1989 Feb; 21(1 Pt 2):1722-5. PubMed ID: 2652563
[No Abstract] [Full Text] [Related]
40. Probable role of suppressor cells and factors in kidney graft survival.
Bensussan A; Klatzmann D; Gluckman JC; Kalil J; Dausset J; Sasportes M
Transplant Proc; 1982 Sep; 14(3):584-7. PubMed ID: 6217608
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
